Application of Endoprosthetic Replacement in Old Patients with Isolated Proximal Femoral Bone Metastases
- PMID: 35606471
- DOI: 10.1245/s10434-022-11912-7
Application of Endoprosthetic Replacement in Old Patients with Isolated Proximal Femoral Bone Metastases
Abstract
Background: Due to radical resection, endoprosthetic reconstruction (EPR) is more invasive and increases the risk of dislocation. Therefore, the suitability of EPR for elderly patients with metastatic tumor needs further investigation.
Methods: Seventy-one adult patients with isolated proximal femoral bone metastases who underwent EPR were retrospectively analyzed and stratified into two groups: elderly age group (≥60 years, n = 31) and younger age group (<60 years, n = 40). The effect of age on prognosis was analyzed to determine whether EPR is beneficial in elderly patients with proximal femoral metastatic tumor. Cox regression modeling was used to evaluate the effect of different factors on postoperative survival outcomes.
Results: Ten (32.26%) and 9 (22.50%) cases of perioperative complications were recorded in the elderly and younger age groups, respectively, with median survival times of 22.00 ± 4.61 months and 23.00 ± 2.85 months, respectively; a log-rank test showed that the difference was not statistically significant (p = 0.657). A Cox regression model was established with patient age as the covariable to evaluate whether it affected postoperative survival. The risk of death due to age was not significant (p = 0.649), but malignancy and femoral metastasis type were significantly associated with postoperative survival (p = 0.001 and p = 0.019).
Conclusion: Although older patients have a slightly higher incidence of postoperative complications than younger patients, they do not experience severe adverse consequences. With rigorous selection and careful preparation, EPR is appropriate for the treatment of proximal femoral metastases in older patients, including those with Harrington type I-II acetabular invasion.
© 2022. Society of Surgical Oncology.
Comment in
-
ASO Author Reflections: Are Older Patients with Proximal Femoral Bone Metastases Fit for Endoprosthetic Replacement?Ann Surg Oncol. 2022 Dec;29(13):8631. doi: 10.1245/s10434-022-11921-6. Epub 2022 May 26. Ann Surg Oncol. 2022. PMID: 35616748 No abstract available.
Similar articles
-
Implant survival and functional results of endoprosthetic reconstruction for proximal femoral metastases with pathological fractures.Hip Int. 2022 Mar;32(2):174-184. doi: 10.1177/11207000211014813. Epub 2021 May 2. Hip Int. 2022. PMID: 33934620
-
ASO Author Reflections: Are Older Patients with Proximal Femoral Bone Metastases Fit for Endoprosthetic Replacement?Ann Surg Oncol. 2022 Dec;29(13):8631. doi: 10.1245/s10434-022-11921-6. Epub 2022 May 26. Ann Surg Oncol. 2022. PMID: 35616748 No abstract available.
-
Surgery for femoral metastases.Bone Joint J. 2020 Mar;102-B(3):285-292. doi: 10.1302/0301-620X.102B3.BJJ-2019-0976.R1. Bone Joint J. 2020. PMID: 32114815
-
Is bipolar hemiarthroplasty an appropriate type of hip articulation following proximal femoral or total femoral resections for musculoskeletal malignancies?Arch Orthop Trauma Surg. 2022 Feb;142(2):331-341. doi: 10.1007/s00402-021-03980-3. Epub 2021 Jun 6. Arch Orthop Trauma Surg. 2022. PMID: 34091707
-
Endoprosthetic reconstruction for large extremity soft-tissue sarcoma with juxta-articular bone involvement: functional and survival outcome.J Surg Res. 2014 Mar;187(1):142-9. doi: 10.1016/j.jss.2013.09.004. Epub 2013 Sep 29. J Surg Res. 2014. PMID: 24405612
Cited by
-
The outcomes of proximal femur replacement with hemiarthroplasty after tumor resection in individuals with Parkinson's disease.Front Surg. 2023 Oct 13;10:1279813. doi: 10.3389/fsurg.2023.1279813. eCollection 2023. Front Surg. 2023. PMID: 37901304 Free PMC article.
-
Risk of complications and implant survival of surgical treatment of proximal femoral metastasis: a meta-analysis.Eur J Orthop Surg Traumatol. 2024 May;34(4):1779-1794. doi: 10.1007/s00590-024-03930-w. Epub 2024 Apr 5. Eur J Orthop Surg Traumatol. 2024. PMID: 38578441 Review.
-
The survival benefit from surgery on patients with large-cell neuroendocrine carcinoma in the lung: a propensity-score matching study.J Cardiothorac Surg. 2023 Jul 5;18(1):216. doi: 10.1186/s13019-023-02314-1. J Cardiothorac Surg. 2023. PMID: 37408065 Free PMC article.
References
-
- Yang Y, Guo W, Wei R. Analysis of clinical prognostic factor for 99 patients with metastases of proximal femur [in Chinese]. Beijing Da Xue Xue Bao Yi Xue Ban. 2012;44(6):895-900
-
- Xu L, Jin J, Hu A, et al. Soft tissue recurrence of giant cell tumor of the bone: prevalence and radiographic features. J Bone Oncol. 2017;9:10–4. https://doi.org/10.1016/j.jbo.2017.09.002 . - DOI - PubMed - PMC
-
- Bostel T, Forster R, Schlampp I, et al. Spinal bone metastases in colorectal cancer: a retrospective analysis of stability, prognostic factors and survival after palliative radiotherapy. Radiat Oncol. 2017;12(1):115. https://doi.org/10.1186/s13014-017-0852-6 . - DOI - PubMed - PMC
-
- Peterson JR, Decilveo AP, O’Connor IT, Golub I, Wittig JC. What are the functional results and complications with long stem hemiarthroplasty in. Clin Orthop Relat Res. 2017;475(3):745–56. https://doi.org/10.1007/s11999-016-4810-7 . - DOI - PubMed
-
- Feng H, Wang J, Guo P, Xu J, Chen W, Zhang Y. CT-guided percutaneous femoroplasty (PFP) for the treatment of proximal femoral metastases. Pain Physician. 2016;19(5):E767–73. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical